RUP response to COVID-19 crisis
Rockefeller University Press stands with the scientific community as we collectively confront the COVID-19 pandemic, and the Journal of Cell Biology (JCB), Journal of Experimental Medicine (JEM), and Journal of General Physiology (JGP) have taken proactive measures to assist researchers during this challenging time.
COVID-19 / SARS-CoV-2 content
RUP is a signatory to the Wellcome statement that commits JCB, JEM, and JGP to:
- make peer-reviewed research articles relevant to the outbreak freely available
- immediately share relevant research findings with the WHO with author knowledge upon journal submission
- recommend authors post relevant research findings to preprint servers, and share final published data as rapidly and widely as possible
- make coronavirus-related publications and the available data supporting them immediately accessible in PubMed Central (PMC). (RUP deposits all articles in PubMed Central (PMC) and archives in LOCKSS/CLOCKSS and Portico on behalf of authors.)
Articles related to COVID-19 / SARS-CoV-2
Viewpoint | March 30, 2020
Forty years with coronaviruses
Susan R. Weiss
Editorial | March 30, 2020
We are here for you and ready to hear from you
Carl F. Nathan, Michel C. Nussenzweig, Teodoro Pulvirenti
Viewpoint | April 14, 2020
COVID-19 and emerging viral infections: The case for interferon lambda
Ludmila Prokunina-Olsson, Noémie Alphonse, Ruth E. Dickenson, Joan E. Durbin, Jeffrey S. Glenn, Rune Hartmann, Sergei V. Kotenko, Helen M. Lazear, Thomas R. O'Brien, Charlotte Odendall, Olusegun O. Onabajo, Helen Piontkivska, Deanna M. Santer, Nancy C. Reich, Andreas Wack, Ivan Zanoni
Perspective | April 16, 2020
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Betsy J. Barnes, Jose M. Adrover, Amelia Baxter-Stoltzfus, Alain Borczuk, Jonathan Cools-Lartigue, James M. Crawford, Juliane Daßler-Plenker, Philippe Guerci, Caroline Huynh, Jason S. Knight, Massimo Loda, Mark R. Looney, Florencia McAllister, Roni Rayes, Stephane Renaud, Simon Rousseau, Steven Salvatore, Robert E. Schwartz, Jonathan D. Spicer, Christian C. Yost, Andrew Weber, Yu Zuo, Mikala Egeblad
Perspective | April 30, 2020
The many faces of the anti-COVID immune response
Santosha A. Vardhana and Jedd D. Wolchok
Viewpoint | June 18, 2020
The renin–angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications
Viewpoint | July 17, 2020
Neutrophils and COVID-19: Nots, NETs, and knots
Viewpoint | July 17, 2020
Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19
Lars M. Koenig, Daniel F.R. Boehmer, Philipp Metzger, Max Schnurr, Stefan Endres, Simon Rothenfusser
Technical Advances and Resources | July 21, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Julio C.C. Lorenzi, Pilar Mendoza, Magdalena Rutkowska, Eva Bednarski, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Marina Caskey, Davide F. Robbiani, Michel C. Nussenzweig, Charles M. Rice, Theodora Hatziioannou, Paul D. Bieniasz
Perspective | July 28, 2020
Role of the early secretory pathway in SARS-CoV-2 infection
Daria Sicari, Aristotelis Chatziioannou, Theodoros Koutsandreas, Roberto Sitia, Roberto Sitia, Eric Chevet, Eric Chevet
People & Ideas | July 31, 2020
Lessons of COVID-19: Virtual conferences
Viewpoint | July 31, 2020
Lessons of COVID-19: A roadmap for post-pandemic science
Tanya S. Freedman, Mark B. Headley, Nina Serwas, Megan Ruhland, Carlos A. Castellanos, Alexis J. Combes, Matthew F. Krummel
Article | August 4, 2020
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Benjamin Israelow, Eric Song, Tianyang Mao, Peiwen Lu, Amit Meir, Feimei Liu, Mia Madel Alfajaro, Jin Wei, Huiping Dong, Robert J. Homer, Aaron Ring, Craig B. Wilen, Akiko Iwasaki
Article | August 12, 2020
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
Fred D. Mast, Arti T. Navare, Almer M. van der Sloot, Jasmin Coulombe-Huntington, Michael P. Rout, Nitin S. Baliga, Alexis Kaushansky, Brian T. Chait, Alan Aderem, Charles M. Rice, Andrej Sali, Mike Tyers, John D. Aitchison
Brief Definitive Report | September 4, 2020
Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients
Youenn Jouan, Antoine Guillon, Loïc Gonzalez, Yonatan Perez, Chloé Boisseau, Stephan Ehrmann, Marion Ferreira, Thomas Daix, Robin Jeannet, Bruno François, Pierre-François Dequin, Mustapha Si-Tahar, Thomas Baranek, Christophe Paget, Christophe Paget
Perspective | September 10, 2020
Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies
Ting Zhou, Tina Tianjiao Su, Tenny Mudianto, Jun Wang
Brief Definitive Report| September 14, 2020
Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
Coraline Radermecker, Nancy Detrembleur, Julien Guiot, Etienne Cavalier, Monique Henket, Céline d’Emal, Céline Vanwinge, Didier Cataldo, Cécile Oury, Cécile Oury, Philippe Delvenne, Philippe Delvenne, Thomas Marichal, Thomas Marichal
Brief Definitive Report| September 14, 2020
SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology
Flavio Protasio Veras, Marjorie Cornejo Pontelli, Camila Meirelles Silva, Juliana E. Toller-Kawahisa, Mikhael de Lima, Daniele Carvalho Nascimento, Ayda Henriques Schneider, Diego Caetité, Lucas Alves Tavares, Isadora M. Paiva, Roberta Rosales, David Colón, Ronaldo Martins, Italo Araujo Castro, Glaucia M. Almeida, Maria Isabel Fernandes Lopes, Maíra Nilson Benatti, Letícia Pastorelli Bonjorno, Marcela Cavichioli Giannini, Rodrigo Luppino-Assad, Sérgio Luna Almeida, Fernando Vilar, Rodrigo Santana, Valdes R. Bollela, Maria Auxiliadora-Martins, Marcos Borges, Carlos Henrique Miranda, Antônio Pazin-Filho, Luis Lamberti P. da Silva, Larissa Cunha, Dario S. Zamboni, Felipe Dal-Pizzol, Luiz O. Leiria, Li Siyuan, Sabrina Batah, Alexandre Fabro, Thais Mauad, Marisa Dolhnikoff, Amaro Duarte-Neto, Paulo Saldiva, Thiago Mattar Cunha, José Carlos Alves-Filho, Eurico Arruda, Paulo Louzada-Junior, Renê Donizeti Oliveira, Fernando Queiroz Cunha
Insights | September 29, 2020
An ace model for SARS-CoV-2 infection
Jack Major, Andreas Wack
Insights | October 6, 2020
An unconventional view of COVID-19 T cell immunity
Hui-Fern Koay, Thomas S. Fulford, Dale I. Godfrey
Viewpoint | October 16, 2020
SARS-CoV-2 vaccine development, access, and equity
Jerome H. Kim
Author and reviewer relief
Although our office is physically closed temporarily, all editorial and publication operations continue. RUP staff members are working remotely.
Many labs have shut down their onsite operations for the next few weeks to help stem the spread of COVID-19. In response, RUP journals are extending their resubmission deadlines for any invited revisions during this time. We are also working proactively with reviewers who need additional time to assess a manuscript and provide comments.
We apologize in advance for any delay our authors may experience.
If you are concerned about your potential submission because of COVID-19 related matters, we also encourage you to contact the relevant editorial staff members using the email addresses above.
Access to all RUP journals content
RUP journals provide authors the choice to select for their research articles Immediate Open Access or open access 6 months after publication, during which time they are available to readers at subscribing institutions.
At all times we offer the following remote access capabilities to subscribed content.
VPN (Virtual Private Network) is software provided to users by their institutions. Users run VPN on their computers, mobile devices or in a standard Web browser to connect securely to their institution’s network from over the Internet. While VPN is enabled, users are on their institution’s network IP address, which allows access to third party resources such as journals and databases. Users with VPN enabled from subscribing institutions should notice no interruption in access to RUP content. Contact your information technology department or librarian for more information.
Affiliated user access
If a user has a free individual user account for one of our journals and is logged on to that account while accessing our content on their institution’s network (on site or via VPN), the individual account is automatically associated with the institution’s access rights. Once associated, when off network and signed with the personal account, access will be granted to all subscribed content. Affiliated access will persist for 90 days after the last visit to the journal while on the institution's network.
An individual can sign in or create a free account via the “Sign In” link at the top right corner of any page on RUP journal websites.
RUP journals support Universal CASA (Campus Activated Subscriber Access). Like affiliated user access, Universal CASA is initiated while on a subscribing institution’s network but the processes take place in the background by Google. Universal CASA is triggered when directly accessing journal content on the subscribing institution's network. There is no need to be logged into a Google account at the time of network access, but if a user is, rights are also associated with the Google account and that account can be used to access subscribed content across devices, even if they have not been on the institution's network.
RUP is proud to participate in the Research4Life initiative that provides developing countries with free access to peer-reviewed content through programs including Hinari: Research for Health, established by the World Health Organization. Additionally, RUP goes a step further and makes all content in our journals freely available via country-wide IP addresses to the countries listed here.
Subscription administrators can set-up Shibboleth federated access via the “Access Options” section of their admin page. More information can be found here. If your federation does not appear in the dropdown menu, please contact us at email@example.com.
OpenAthens is now available for RUP journals. OpenAthens establishes one set of log-in credentials for all web resources and applications. Users log-on once via their home organization to access multiple online services, anytime and anywhere. Learn more at https://openathens.org or log into your account at openathens.net.
CERNET Authentication and Resource Sharing Infrastructure (CARSI) is the Identity Federation and resource sharing service of CERNET—China Education and Research Network. CARSI is introduced to facilitate and simplify the process of shared services among the Federation members in CERNET. It is a multi-organization association effected by using Identity Federation Technologies to extend the scope of a digital identity issued by one Federation Member to be valid across the whole Federation to promote the user identity resources and application resources sharing among members. For more information, visit https://www.carsi.edu.cn/index_zh.htm.
The RUP office at 950 3rd Ave. New York, NY, is temporarily closed. Staff members are working remotely and can be reached via email and phone, with email communication preferred. We thank you for your patience and understanding if there is a delay in response as we tend to our family, friends, and community.